| Katherine Lynn Mccarter, CADCII | |
|
58646 Mcnulty Way, Saint Helens, OR 97051-6210 | |
| (503) 397-5211 | |
| (503) 397-5373 |
| Full Name | Katherine Lynn Mccarter |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 58646 Mcnulty Way, Saint Helens, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114115755 | NPI | - | NPPES |
| 123190 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| 171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Lynn Mccarter, CADCII Po Box 1234, Saint Helens, OR 97051-8234 Ph: (503) 397-5211 | Katherine Lynn Mccarter, CADCII 58646 Mcnulty Way, Saint Helens, OR 97051-6210 Ph: (503) 397-5211 |
News Archive
Elan Corporation, plc today reported its second quarter and first half 2012 financial results.
BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).
A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.
Resverlogix Corp. has announced that it has received approval by the US Food and Drug Administration (FDA) to initiate a Phase 1a clinical trial of oral RVX-208 in the USA. RVX-208 is a novel first-in-class small molecule that increases the production of ApoA-I and HDL.
Onyx Pharmaceuticals, Inc. today announced the initiation of a Phase 1 study of ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent solid tumors.
› Verified 5 days ago
Sandra Anne Petersen-tetz, CADC I Counselor Medicare: Not Enrolled in Medicare Practice Location: 185 N 4th St, Saint Helens, OR 97051 Phone: 503-366-4540 Fax: 503-366-4526 | |
Ruth Deleon, M.A, Counselor Medicare: Not Enrolled in Medicare Practice Location: 58646 Mcnulty Way, Saint Helens, OR 97051 Phone: 503-397-5211 | |
Megan J Parks, Counselor Medicare: Not Enrolled in Medicare Practice Location: 58646 Mcnulty Way, Saint Helens, OR 97051 Phone: 503-397-5211 | |
Heather Lorene Swanson, B.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 58646 Mcnulty Way, Saint Helens, OR 97051 Phone: 503-397-5211 | |
Ben Louis Weaver, LPC, NCC, QMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 58646 Mcnulty Way, Saint Helens, OR 97051 Phone: 503-397-5211 Fax: 503-438-2194 | |
Sierra Marie Dibble, Counselor Medicare: Not Enrolled in Medicare Practice Location: 58147 Columbia River Hwy Ste C, Saint Helens, OR 97051 Phone: 503-396-5322 | |
Tabatha L Bird Weaver, LPC,MA, MFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 58646 Mcnulty Way, Saint Helens, OR 97051 Phone: 503-397-5211 Fax: 503-397-5373 |